US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CST Brands Inc

48.53

0.0000

Volume:- -

Turnover:- -

Market Cap:3.68B

PE:11.45

High:48.53

Open:48.53

Low:48.53

Close:48.53

52wk High:48.56

52wk Low:40.85

Shares:75.93M

Float Shares:75.10M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):4.24

ROE:--

ROA:--

PB:2.08

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update

Press Release: Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CST"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CST\",,,,,undefined,":{"symbol":"CST","market":"US","secType":"STK","nameCN":"CST Brands Inc","latestPrice":48.53,"timestamp":1575666000000,"preClose":48.53,"halted":4,"volume":0,"delay":0,"floatShares":75100000,"shares":75925000,"eps":4.24,"marketStatus":"Delisted","change":0,"latestTime":"12-06 16:00:00 EST","open":48.53,"high":48.53,"low":48.53,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.24,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1759737600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":48.53,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CST\",,,,,undefined,":{"symbol":"CST","floatShares":75100000,"roa":"--","roe":"--","lyrEps":0,"shares":75925000,"dividePrice":0,"high":48.53,"amplitude":0,"preClose":48.53,"low":48.53,"week52Low":40.85,"pbRate":"2.08","week52High":48.555,"institutionHeld":0,"latestPrice":48.53,"eps":4.24,"divideRate":0,"volume":0,"delay":0,"ttmEps":4.24,"open":48.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CST\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-05-08","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1494216000000,"reportTimeType":"post","actualEps":0.15},{"market":"US","date":"2017-02-27","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1488171600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-11-07","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.63,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1478494800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-08-05","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1470369600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-06","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1462507200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CST\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CST\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564892718","title":"Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2564892718","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564892718?lang=en_us&edition=fundamental","pubTime":"2025-09-01 16:00","pubTimestamp":1756713600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, Sept.  01, 2025  (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data ana","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/01/3142014/0/en/Oculis-to-Present-Clinical-Trial-Results-in-Diabetic-Macular-Edema-and-Acute-Optic-Neuritis-at-Ophthalmology-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CST","EIS","OCS"],"gpt_icon":0},{"id":"2556851228","title":"4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2556851228","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556851228?lang=en_us&edition=fundamental","pubTime":"2025-08-01 04:05","pubTimestamp":1753992300,"startTime":"0","endTime":"0","summary":"4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level4D-150 demonstrated durable and dose-dependent clinical activity with sustained gains in v","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/31/3125378/0/en/4DMT-Presents-Positive-60-Week-Results-from-4D-150-SPECTRA-Clinical-Trial-in-DME-and-Regulatory-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4605","BK4529","LU1880398554.USD","BK4588","BK4543","CST","LU0390134368.USD","LU0823434583.USD","BK4532","BK4534","LU0127658192.USD","LU0056508442.USD","LU2054465674.USD","LU0889565833.HKD","LU0081259029.USD","BK4575","IE00BMPRXN33.USD","LU0823434740.USD","LU1989764664.SGD","LU2098885051.SGD","IE00BMPRXR70.SGD","BK4614","IE00B5949003.HKD","LU0823421416.USD","LU2360106780.USD","LU2250418816.HKD","EMA","LU0642271901.SGD","LU1803068979.SGD","LU2458330243.SGD","IE0004445239.USD","IE0009356076.USD","BK4081","LU2458330169.SGD","BK4512","LU1951198990.SGD","LU1064131342.USD","MAA","BK4585","BK4554","LU0082616367.USD","LU2264538146.SGD","GFS","LU1880398471.USD","LU0198837287.USD","BK4566","LU1852331112.SGD","LU0109392836.USD","BK4141"],"gpt_icon":1},{"id":"2537984961","title":"Press Release: Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2537984961","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537984961?lang=en_us&edition=fundamental","pubTime":"2025-05-21 18:45","pubTimestamp":1747824300,"startTime":"0","endTime":"0","summary":"Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation. GALWAY, Ireland, May 21, 2025 /CNW/ -- Medtronic plc , a global leader in healthcare technology, today announced financial results for its fourth quarter  and fiscal year 2025 , which ended April 25, 2025.-- Q4 revenue of $8.9 billion increased 3.9% as reported and 5.4% organic. -- Q4 GAAP diluted EPS of $0.82 increased 67%; non-GAAP diluted EPS of $1.62. -- Q4 operating margin increased 380 basis points; Q4 non-GAAP operating. -- Cardiac Ablation Solutions Q4 revenue increased nearly 30% on strength of. pulsed field ablation  products; business delivered $1.0 billion in.  for a urologic indication in the first quarter of calendar 2025. operating profit of $8.7 billion increased 5%, 9% constant currency. Q4 GAAP operating profit and operating margin were $1.436 billion and 16.1%, respectively, increases of 36% and 380 basis points, respectively. As","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","03160","LU0072461881.USD","CAS","LU2028103732.USD","LU0211326839.USD","IE00BQXX3C00.GBP","LU0976567544.SGD","LU2468319806.SGD","LU0070302665.USD","IE000M9KFDE8.USD","TM","BK4566","IE00BFXG1179.USD","LU2023251221.USD","LU0158827948.USD","MDT","LU0265550946.USD","BK4099","LU0162691827.USD","LU2089284900.SGD","BK4604","LU2111349929.HKD","LU0158827781.USD","LU0208291251.USD","CST","LU0211331839.USD","LU0265550359.USD","LU1116320737.USD","IE00BQXX3F31.USD","LU2089283258.USD","LU2089984988.USD","BK4585","IE00B3T34201.USD","BK4082","LU0211326755.USD","BK4533","BK4588","LU1291159041.SGD","LU2271345857.HKD","DBS","BK4555","LU0496365809.HKD","LU1116320901.HKD","IE00BQXX3D17.EUR","LU1989764748.USD","LU1989771016.USD","LU1983299246.USD","LU1989764664.SGD"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CST\",params:#limit:6,delay:false,,,undefined,":[]}}